[1] |
LEWIN A C, KOLB A W, MCLELLAN G J, et al. Genomic, recombinational and phylogenetic characterization of global feline herpesvirus 1 isolates[J]. Virology, 2018, 518:385-397.
|
[2] |
DIGANGI B A, GRAY L K, LEVY J K, et al. Detection of protective antibody titers against feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus in shelter cats using a point-of-care ELISA[J]. J Feline Med Surg, 2011, 13(12):912-918.
|
[3] |
DALL'ARA P, LABRIOLA C, SALA E, et al. Prevalence of serum antibody titres against feline panleukopenia, herpesvirus and calicivirus infections in stray cats of Milan, Italy[J]. Prev Vet Med, 2019, 167:32-38.
|
[4] |
BERGMANN M, SPECK S, RIEGER A, et al. Antibody response to feline herpesvirus-1 vaccination in healthy adult cats[J]. J Feline Med Surg, 2020, 22(4):329-338.
|
[5] |
HELPS C R, LAIT P, DAMHUIS A, et al. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats:experience from 218 European catteries[J]. Vet Rec, 2005, 156(21):669-673.
|
[6] |
FERNANDEZ M, MANZANILLA E G, LLORET A, et al. Prevalence of feline herpesvirus-1, feline calicivirus, Chlamydophila felis and Mycoplasma felis DNA and associated risk factors in cats in Spain with upper respiratory tract disease, conjunctivitis and/or gingivostomatitis[J]. J Feline Med Surg, 2017, 19(4):461-469.
|
[7] |
LIU C H, LIU Y X, QIAN P, et al. Molecular and serological investigation of cat viral infectious diseases in China from 2016 to 2019[J]. Transbound Emerg Dis, 2020, 67(6):2329-2335.
|
[8] |
SCHULZ C, HARTMANN K, MUELLER R S, et al. Sampling sites for detection of feline herpesvirus-1, feline calicivirus and Chlamydia felis in cats with feline upper respiratory tract disease[J]. J Feline Med Surg, 2015, 17(12):1012-1019.
|
[9] |
HUSSEIN I T M, FIELD H J. Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compounds[J]. J Virol Methods, 2008, 152(1-2):85-90.
|
[10] |
MAZZEI M, VASCELLARI M, ZANARDELLO C, et al. Quantitative real time polymerase chain reaction (qRT-PCR) and RNAscope in situ hybridization (RNA-ISH) as effective tools to diagnose feline herpesvirus-1-associated dermatitis[J]. Vet Dermatol, 2019, 30(6):491-e147.
|
[11] |
CHEN J, MA E B, HARRINGTON L, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity[J]. Science, 2018, 360(6387):436-439.
|
[12] |
BROUGHTON J P, DENG X D, YU G X, et al. CRISPR-Cas12-based detection of SARS-CoV-2[J]. Nat Biotechnol, 2020, 38(7):870-874.
|
[13] |
HENZEL A, BRUM M C S, LAUTERT C, et al. Isolation and identification of feline calicivirus and feline herpesvirus in southern Brazil[J]. Braz J Microbiol, 2012, 43(2):560-568.
|
[14] |
TOWNSEND W M, JACOBI S, TAI S H, et al. Ocular and neural distribution of feline herpesvirus-1 during active and latent experimental infection in cats[J]. BMC Vet Res, 2013, 9:185.
|
[15] |
LIU M Z, HAN X H, YAO L Q, et al. Development and application of a simple recombinase polymerase amplification assay for rapid point-of-care detection of feline herpesvirus type 1[J]. Arch Virol, 2019, 164(1):195-200.
|
[16] |
WANG J C, LIU L B, WANG J F, et al. Recombinase polymerase amplification assay-a simple, fast and cost-effective alternative to real time PCR for specific detection of Feline herpesvirus-1[J]. PLoS One, 2017, 12(1):e0166903.
|
[17] |
TAN Y X, DONG G Y, XU H F, et al. Development of a cross-priming isothermal amplification assay based on the glycoprotein B gene for instant and rapid detection of feline herpesvirus type 1[J]. Arch Virol, 2020, 165(3):743-747.
|